Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
about
Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerOcular toxicity in low-dose tamoxifen: a prospective studySmall optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy.An estrogen receptor repressor induces cataract formation in transgenic mice.A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort studyEvaluation of adverse effects in tamoxifen exposed healthy female dogsBreast cancer medications and vision: effects of treatments for early-stage disease.Lens opacification by antioestrogens: tamoxifen vs ICI 182,780.Ocular toxicity from systemically administered xenobiotics.Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.Drug-induced macular edema.Risks and benefits associated with hormonal and surgical therapies for healthy midlife women.Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells.Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407.Ocular toxicity and cancer chemotherapy. A review.A study of the effects of tamoxifen in the frail elderly: difficulties encountered in nursing home research.Retinal changes associated with tamoxifen treatment for breast cancer.Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy?Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.Ocular findings in breast cancer patients using tamoxifen.To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2.
P2860
Q24685693-E3838DE5-EABE-40E7-9D16-3B6100C81EADQ28372746-B51DE74F-5DF6-449C-895D-5D9EF4DB6CDEQ33239343-ADB9D87E-DC4D-4576-A3FC-F4688A3729CDQ34035580-E9519A51-8DB1-43FA-ACDC-72C6E1F45310Q34252972-05865B39-66F5-4C56-9CCC-4E65C77CB33CQ34498467-B0313FFE-4D68-41E2-A8EF-B0BC1DCE233DQ35496778-27204F4E-7DAA-4999-93BF-18AC94FD01F1Q35872708-9A3EF3A1-F9EE-47D9-9CB2-B9CE8424DD7CQ35892547-8B378462-8950-427C-9DED-FBE4787C04CCQ36422772-50D9ED01-002A-4D76-8BE1-23A465A751C5Q38103823-7686DC64-04A9-434D-9852-E518E35DDEC8Q40650368-9100F264-716D-431F-BB29-3DAC6858A61BQ40690857-B157EA27-886C-4B49-9861-BDA0383C255CQ40709136-59122E71-B390-4749-9416-784B082C0DF6Q41137774-29515647-FA95-452F-8790-27D2165C82BDQ41559245-8E7408CB-EA93-430C-BEB5-27BC42A4589DQ41646279-0949113C-A590-4727-92B0-DE2DF7B45322Q41700375-ABFB1A5C-6A51-4116-87CC-CBF9248DCB51Q44364366-16EEBC3B-3913-44ED-A4C9-1C1A47CFD24FQ45029964-31C5A7E2-5C93-4DF5-9401-1160E050CFC7Q50224137-3782CC2B-5FDA-4636-A74E-66ACAC1F200EQ52818818-A4748C86-759E-4679-8145-D8B4509664CCQ55275799-422E6EE4-4FE1-44A0-8334-DFB9730E1741
P2860
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Clear evidence that long-term, ...... spective study of 63 patients.
@ast
Clear evidence that long-term, ...... spective study of 63 patients.
@en
type
label
Clear evidence that long-term, ...... spective study of 63 patients.
@ast
Clear evidence that long-term, ...... spective study of 63 patients.
@en
prefLabel
Clear evidence that long-term, ...... spective study of 63 patients.
@ast
Clear evidence that long-term, ...... spective study of 63 patients.
@en
P2093
P1433
P1476
Clear evidence that long-term, ...... spective study of 63 patients.
@en
P2093
Briassoulis E
Pavlidis NA
Petroutsos G
Rempapis J
P304
P356
10.1002/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W
P407
P577
1992-06-01T00:00:00Z